Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients...
Enregistré dans:
Auteurs principaux: | Despoina-Rafailia Benetou, Charalampos Varlamos, Christos Pappas, Fotios Kolokathis, Dimitrios Alexopoulos |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5b6f64e6a44a4cc9b162c9ac93c3aff0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
par: Charalampos Varlamos, et autres
Publié: (2021) -
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
par: Dimitrios Alexopoulos, et autres
Publié: (2020) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
par: Despoina-Rafailia Benetou, et autres
Publié: (2021) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
par: Iosif Xenogiannis, et autres
Publié: (2021) -
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
par: Tamara García Camarero, et autres
Publié: (2020)